Display options
Cite
Park SY, Mosci C, Kumar M, et al. Initial evaluation of (4S)-4-(3-[. EJNMMI Res. 2020;10(1):100doi: 10.1186/s13550-020-00678-2.
Park, S. Y., Mosci, C., Kumar, M., Wardak, M., Koglin, N., Bullich, S., Mueller, A., Berndt, M., Stephens, A. W., Chin, F. T., Gambhir, S. S., & Mittra, E. S. (2020). Initial evaluation of (4S)-4-(3-[. EJNMMI research, 10(1), 100. https://doi.org/10.1186/s13550-020-00678-2
Park, Sonya Y, et al. "Initial evaluation of (4S)-4-(3-[." EJNMMI research vol. 10,1 (2020): 100. doi: https://doi.org/10.1186/s13550-020-00678-2
Park SY, Mosci C, Kumar M, Wardak M, Koglin N, Bullich S, Mueller A, Berndt M, Stephens AW, Chin FT, Gambhir SS, Mittra ES. Initial evaluation of (4S)-4-(3-[. EJNMMI Res. 2020 Aug 28;10(1):100. doi: 10.1186/s13550-020-00678-2. PMID: 32857284; PMCID: PMC7455665.
Copy Download .nbib Format: NLM
Share it on

EJNMMI Res. 2020 Aug 28;10(1):100. doi: 10.1186/s13550-020-00678-2.

Initial evaluation of (4S)-4-(3-[.

EJNMMI research

Sonya Y Park, Camila Mosci, Meena Kumar, Mirwais Wardak, Norman Koglin, Santiago Bullich, Andre Mueller, Mathias Berndt, Andrew W Stephens, Frederick T Chin, Sanjiv S Gambhir, Erik S Mittra

Affiliations

  1. Department of Radiology, Division of Nuclear Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  2. Molecular Imaging Program at Stanford (MIPS), Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA.
  3. Bayer Pharma AG, Berlin, Germany.
  4. Life Molecular Imaging GmbH, Berlin, Germany.
  5. Department of Bioengineering, Stanford University, Stanford, CA, USA.
  6. Department of Materials Science & Engineering, Stanford University, Stanford, CA, USA.
  7. Bio-X Program, Stanford University, Stanford, CA, USA.
  8. Molecular Imaging Program at Stanford (MIPS), Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA. [email protected].
  9. Department of Diagnostic Radiology, Division of Nuclear Medicine & Molecular Imaging, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Mail Code L340, Portland, OR, 97239, USA. [email protected].

PMID: 32857284 PMCID: PMC7455665 DOI: 10.1186/s13550-020-00678-2

Abstract

PURPOSE: (4S)-4-(3-[

METHODS: A total of 15 subjects with HNC (n = 5), CRC (n = 5), or NHL (n = 5) were recruited (mean age 66.2 years, range 44-87 years). 301.4 ± 28.1 MBq (8.1 ± 0.8 mCi) of [

RESULTS: [

CONCLUSIONS: [

Keywords: Colorectal cancer; Glutamate; Head and neck cancer; Lymphoma; PET/CT; Positron emission tomography; [18F]FSPG; xC− transporter

References

  1. J Nucl Med. 1995 Oct;36(10):1790-6 - PubMed
  2. PLoS One. 2015 Apr 08;10(4):e0122756 - PubMed
  3. J Biol Chem. 2017 Aug 25;292(34):14240-14249 - PubMed
  4. PLoS One. 2016 Feb 18;11(2):e0148628 - PubMed
  5. J Nucl Med. 2008 Mar;49(3):480-508 - PubMed
  6. Cell. 2017 Feb 9;168(4):657-669 - PubMed
  7. Nat Commun. 2017 Apr 21;8:15074 - PubMed
  8. Cancer Lett. 2015 Nov 1;368(1):88-96 - PubMed
  9. J Nucl Med. 2013 Jun;54(6):861-6 - PubMed
  10. Hell J Nucl Med. 2009 Jan-Apr;12(1):26-9 - PubMed
  11. Science. 2009 May 22;324(5930):1029-33 - PubMed
  12. Clin Cancer Res. 2011 Sep 15;17(18):6000-11 - PubMed
  13. Leukemia. 2001 Oct;15(10):1633-40 - PubMed
  14. J Nucl Med. 2016 Jan;57(1):67-9 - PubMed
  15. J Nucl Med. 2014 Dec;55(12):2038-44 - PubMed
  16. J Cell Physiol. 2008 Jun;215(3):593-602 - PubMed
  17. Clin Cancer Res. 2019 Apr 15;25(8):2471-2482 - PubMed
  18. J Nucl Med. 2013 Jan;54(1):117-23 - PubMed
  19. Radiology. 2016 Jun;279(3):898-905 - PubMed
  20. Cancer Res. 2019 Feb 15;79(4):853-863 - PubMed
  21. J Natl Compr Canc Netw. 2009 Jun;7 Suppl 2:S1-26 - PubMed
  22. Nucl Med Commun. 2008 Dec;29(12):1046-51 - PubMed
  23. Lancet Oncol. 2001 Mar;2(3):157-64 - PubMed
  24. Proc Natl Acad Sci U S A. 2019 May 7;116(19):9533-9542 - PubMed
  25. Clin Radiol. 2011 Apr;66(4):366-82 - PubMed
  26. Clin Cancer Res. 2012 Mar 15;18(6):1696-703 - PubMed
  27. Eur J Haematol. 2011 Jan;86(1):32-7 - PubMed
  28. Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):10964-9 - PubMed
  29. J Nucl Med. 2017 Apr;58(4):533-537 - PubMed
  30. J Clin Invest. 2013 Sep;123(9):3678-84 - PubMed
  31. J Nucl Med. 2019 Dec;60(12):1812-1817 - PubMed
  32. Cancer. 2014 Nov 15;120(22):3433-45 - PubMed
  33. J Nucl Med. 2017 Mar;58(3):367-373 - PubMed
  34. J Nucl Med. 2014 Apr;55(4):657-64 - PubMed
  35. Mol Imaging Biol. 2016 Dec;18(6):924-934 - PubMed
  36. Cancer Res. 2013 Mar 15;73(6):1855-66 - PubMed
  37. Nat Cell Biol. 2020 Apr;22(4):476-486 - PubMed
  38. Antioxid Redox Signal. 2013 Feb 10;18(5):522-55 - PubMed
  39. Radiographics. 1999 Jan-Feb;19(1):61-77; quiz 150-1 - PubMed
  40. Science. 2020 Apr 3;368(6486):85-89 - PubMed
  41. Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):810-820 - PubMed
  42. J Nucl Med. 2012 Jan;53(1):21-8 - PubMed
  43. Clin Cancer Res. 2012 Oct 1;18(19):5427-37 - PubMed
  44. AJR Am J Roentgenol. 2007 Nov;189(5):1203-10 - PubMed
  45. Cell Biochem Biophys. 2013 May;66(1):37-43 - PubMed

Publication Types

Grant support